$3.05B
$1.73 Billion
0.35% of portfolio
30,941
Q4 2024
New
$71.6M
$1.78 Billion
0.35% of portfolio
134,798
Q4 2024
Reduced 45.23%
Palvella Therapeutics Inc Ne
-
$1.74 Billion
0.35% of portfolio
-
Q4 2024
New
$1.21B
$1.69 Billion
0.34% of portfolio
31,509
Q4 2024
Added 142.38%
-
$1.66 Billion
0.33% of portfolio
-
Q4 2024
Added 268.3%
$5.08B
$1.66 Billion
0.33% of portfolio
19,661
Q4 2024
Added 3,176.83%
-
$1.53 Billion
0.31% of portfolio
-
Q4 2024
Reduced 28.0%
-
$1.53 Billion
0.3% of portfolio
-
Q3 2024
New
$10.6B
$1.52 Billion
0.3% of portfolio
21,974
Q4 2024
Added 504.68%
$776M
$1.48 Billion
0.3% of portfolio
120,000
Q4 2024
New
-
$1.4 Billion
0.28% of portfolio
-
Q4 2024
Added 731.71%
$3.82B
$1.35 Billion
0.27% of portfolio
29,100
Q4 2024
Added 191.0%
$815M
$1.29 Billion
0.26% of portfolio
134,109
Q4 2024
New
$338M
$1.32 Billion
0.26% of portfolio
170,129
Q4 2024
Reduced 70.1%
$13.7B
$1.27 Billion
0.25% of portfolio
49,963
Q4 2024
Reduced 95.44%
Contineum Therapeutics Inc
-
$1.2 Billion
0.24% of portfolio
-
Q4 2024
Added 817.07%
-
$1.2 Billion
0.24% of portfolio
-
Q4 2024
New
$623M
$1.2 Billion
0.24% of portfolio
337,676
Q4 2024
Reduced 39.39%
-
$1.12 Billion
0.22% of portfolio
-
Q4 2024
Added 196.51%
$782B
$1.04 Billion
0.21% of portfolio
1,350
Q4 2024
Added 17.39%
-
$1.02 Billion
0.2% of portfolio
-
Q4 2024
Reduced 12.73%
$225M
$1.01 Billion
0.2% of portfolio
131,599
Q4 2024
Reduced 65.07%
-
$991 Million
0.2% of portfolio
-
Q4 2024
Reduced 88.99%
-
$985 Million
0.2% of portfolio
-
Q4 2024
Reduced 79.2%
$68.3B
$969 Million
0.19% of portfolio
1,361
Q4 2024
Added 56.26%
$1.56B
$950 Million
0.19% of portfolio
38,312
Q4 2024
Reduced 12.73%
$141B
$930 Million
0.19% of portfolio
35,050
Q4 2024
Reduced 2.5%
Structure Therapeutics Inc
-
$958 Million
0.19% of portfolio
-
Q4 2024
New
$1.47B
$944 Million
0.19% of portfolio
17,424
Q4 2024
Reduced 25.72%
$1.98B
$914 Million
0.18% of portfolio
44,826
Q4 2024
Reduced 55.98%
$157M
$922 Million
0.18% of portfolio
196,248
Q4 2024
Added 251.69%
$150B
$918 Million
0.18% of portfolio
4,000
Q4 2024
New
$1.7B
$843 Million
0.17% of portfolio
19,505
Q4 2024
Added 62.54%
Agriculture & Nat Sol Acq CO
-
$843 Million
0.17% of portfolio
-
Q3 2024
New
$27M
$825 Million
0.16% of portfolio
801,277
Q4 2024
Added 7.78%
Keen Vision Acquisition Corp
-
$824 Million
0.16% of portfolio
-
Q4 2023
New
$86.5M
$813 Million
0.16% of portfolio
90,984
Q4 2024
Reduced 2.47%
$280M
$774 Million
0.15% of portfolio
56,120
Q4 2024
Added 130.88%
Neumora Therapeutics Inc.
-
$727 Million
0.15% of portfolio
-
Q4 2024
New
$33B
$682 Million
0.14% of portfolio
2,900
Q4 2024
New
$107M
$696 Million
0.14% of portfolio
368,330
Q4 2024
Reduced 14.1%
$141M
$719 Million
0.14% of portfolio
126,792
Q4 2024
Added 212.03%
-
$712 Million
0.14% of portfolio
-
Q4 2024
New
$593M
$672 Million
0.13% of portfolio
53,023
Q4 2024
Reduced 0.17%
-
$670 Million
0.13% of portfolio
-
Q4 2024
New
Kiora Pharmaceuticals Inc
-
$661 Million
0.13% of portfolio
-
Q4 2024
Added 1.87%
$51.6M
$648 Million
0.13% of portfolio
122,690
Q4 2024
New
-
$672 Million
0.13% of portfolio
-
Q3 2024
Reduced 22.78%
-
$605 Million
0.12% of portfolio
-
Q4 2024
Added 33.75%
-
$596 Million
0.12% of portfolio
-
Q4 2024
Reduced 87.0%